Altermune Technologies
Latest round
- Seed
Last raised
- Sep 2011
Total raised
- $7M
Investors
- 1
About Altermune Technologies
Altermune Technologies, LLC, founded in 2011 and headquartered in Irvine, US, focuses on domain name sales and leasing. The company has engaged in 2 deals, with the most recent deal on January 19, 2016, involving Centauri Therapeutics’ acquisition of the Alphamer technology for drug discovery.com specializes in the sale and leasing of domain names, offering a straightforward platform for individuals and businesses seeking to acquire online assets. Their core service includes providing the option to purchase a domain name outright for USD 9,995 or to choose a leasing arrangement with a monthly payment plan of USD 480.com is primarily structured around direct sales and leasing agreements for domain names. Clients engage with the company through purchases or leasing options, with transactions typically involving a one-time payment of USD 9,995 for outright sales or a monthly subscription fee of USD 480 for leasing.Altermune Technologies plans to enhance its offerings with new products aimed at expanding its domain name inventory and improving user experience. The company is targeting growth in emerging markets, particularly in Asia-Pacific, by 2024.00 mn from Loxbridge Research will support these initiatives and help facilitate the geographic expansion efforts.
Who invested in Altermune Technologies
1 investor across 1 round
See all investors in Altermune Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 22, 2011
Amount
$7M
Investors
Questions about Altermune Technologies
Who invested in Altermune Technologies?
Altermune Technologies has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Altermune Technologies raised?
Altermune Technologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Altermune Technologies last raise money?
Altermune Technologies's most recent round on record is a Seed, in Sep 2011.
What does Altermune Technologies do?
Altermune Technologies, LLC, founded in 2011 and headquartered in Irvine, US, focuses on domain name sales and leasing.
Where is Altermune Technologies headquartered?
Altermune Technologies is headquartered in Irvine, US.
Which VCs invest in companies like Altermune Technologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Altermune Technologies's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like Altermune Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.